Pain News and Research

Latest Pain News and Research

Co-occurrence of medical and psychiatric disease is likely to affect QoL

This review provides evidence of a substantially reduced psychosocial and physical quality of life in medically ill patients with comorbid mental disorders. This patient-reported outcome highlights the importance of recognizing and treating comorbid mental disorders in the medically ill.

7 Oct 2011

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.

7 Oct 2011

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.

7 Oct 2011

Viewpoints: Jobs and 'Obamacare;' jurisdictional barriers to health law challenges; reforming provider payment

By most of the usual measures, President Obama has no business being reelected. Here's why he might be anyway. On Wednesday morning, as Senate Democratic leaders were scrambling to find a way to enact part of Obama's jobs bill, a dozen Republican lawmakers assembled outside the Capitol to complain about ... health-care reform.

7 Oct 2011

FDA grants 510(k) clearance to Carticept Medical's Navigator Delivery System

Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has received 510(k) clearance from the Food and Drug Administration to market its Navigator™ Delivery System (Navigator DS) in the United States.

4 Oct 2011

Merck wins fourth FOSAMAX trial

Merck, known as MSD outside the United States and Canada, today said a federal court jury in New York found in its favor in the Secrest v. Merck case, rejecting the claim of a Florida woman who blamed her dental and jaw-related problems on her FOSAMAX use.

4 Oct 2011

Lipomannan on TB bacterium's outer cell surface can block TNF production

The bacterium that causes tuberculosis has a unique molecule on its outer cell surface that blocks a key part of the body's defense. New research suggests this represents a novel mechanism in the microbe's evolving efforts to remain hidden from the human immune system.

4 Oct 2011

Creabilis receives $20 million in Series B funding

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, inflammation and pain, has raised €15 million ($20 million) in a Series B funding round led by Abbott Biotech Ventures.

4 Oct 2011

MR-guided focused ultrasound may effectively control essential tremor

In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million Americans.

4 Oct 2011

Latest findings on cancer to be presented at 10th AACR international conference

What: The 10th AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists to share the latest findings in genetics, chemoprevention and lifestyle choices that may prevent cancer.

4 Oct 2011

Federal officials extend Ariz. Medicaid program while reviewing new plan; Wis. announces eligibility changes to cut budget shortfall

In other state Medicaid news, doctors in Washington state are suing to stop a new rule that limits enrollees' visits to the emergency department and Gov. Cuomo's administration dismisses a proposal for N.Y. to pay for transgender surgery.

4 Oct 2011

Sangamo's SB-509 fails to meet key endpoints in Phase 2b study for diabetic neuropathy

Sangamo BioSciences, Inc. today announced that its Phase 2b study (SB-509-901) did not meet its primary or secondary clinical endpoints in subjects with moderate severity diabetic neuropathy (DN) as compared to placebo.

3 Oct 2011

Anesthesia and liposuction

Liposuction is a body contouring procedure, not a cure for obesity. The results are judged with a mirror and not a scale. The procedure is ideally suited for men and women with localized fat deposits that are resistant to diet and exercise. Men typically want their "spare tire" and excess fat on their chest removed, while women want their abdomen, hips, and thighs reduced.

3 Oct 2011

Alkermes initiates ALKS 37 phase 2b study in opioid-induced constipation

Alkermes plc today announced the initiation of a phase 2b study of ALKS 37, an orally active, peripherally restricted opioid antagonist for the treatment of opioid-induced constipation.

3 Oct 2011

Vexim obtains registration certificate for SpineJack in India

Vexim, the Med-Tech specialist in the minimally invasive, anatomical treatment of vertebral compression fractures, today announced that it has obtained the registration certificate for SpineJack in India.

3 Oct 2011

Improper footwear may lead to severe foot pain, impairment and disability in gout patients

New research shows that use of poor footwear is common among patients with gout. According to the study published in Arthritis Care & Research, a peer-reviewed journal of the American College of Rheumatology (ACR), gout patients who make poor footwear choices experienced higher foot-related pain, impairment and disability. Gout patients also reported that comfort, fit, support and cost were the most important factors for selecting footwear.

3 Oct 2011

FDA releases new PSA on safe medication use

The U.S. Food and Drug Administration (FDA) Office of Women's Health today released a new public service announcement (PSA) titled, "Use Medicines Wisely," to help raise awareness about safe medication use.

3 Oct 2011

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

David, a 67-year-old father of three and soon to be first-time grandfather, felt too young to be diagnosed with prostate cancer. "I felt great," he said. "I had no symptoms." David, under the advisement of his oncologist, decided to be treated with PROVENGE (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies.

1 Oct 2011

Vejthani Hospital brings Digital Lightbox to help surgeon plan the surgery pre-operatively

Vejthani Hospital Bangkok brought intelligent medical equipment in Orthopedic Knee Surgery, the so called "Digital lightbox", this can be used to enhance the capability of the Image Guided surgery (Computer Assisted Navigation System) for total joint replacement surgery.

1 Oct 2011

CSRO survey explores impact of health insurance barriers

The Coalition of State Rheumatology Organizations today released the findings of a nationwide survey that explored the impact of health insurance barriers such as prior authorization and step therapy on the ability of rheumatologists to provide effective care to patients.

1 Oct 2011